Phase 2 multicentre study of single-agent ofatumumab in previously untreated follicular lymphoma: CALGB 50901 (Alliance)
British Journal of Haematology | Feb 11, 2019
The efficacy and safety of sunitinib given on an individualised schedule as first-line therapy for metastatic renal cell carcinoma: A phase 2 clinical trial
European Journal of Cancer | Feb 10, 2019
Randomised phase 2 study of pembrolizumab plus CC-486 vs pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer
European Journal of Cancer | Feb 10, 2019
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
European Journal of Cancer | Feb 10, 2019
Trazodone use and risk of dementia: A population-based cohort study
PLoS Neglected Tropical Diseases | Feb 10, 2019
Treatment with direct-acting antivirals for HCV decreases but does not eliminate the risk of hepatocellular carcinoma
Liver International | Feb 10, 2019
The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age
Pediatric Allergy and Immunology | Feb 10, 2019
Erectile dysfunction medications and skin cancer: An analysis in US Veterans
Urology | Feb 10, 2019